We serve Chemical Name:tert-butyl N-[[(3R)-1-benzylpyrrolidin-3-yl]methyl]carbamate CAS:852857-09-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![tert-butyl N-[[(3R)-1-benzylpyrrolidin-3-yl]methyl]carbamate](https://a.dearchem.com/CAS2/852857-09-1.png)
Chemical Name:tert-butyl N-[[(3R)-1-benzylpyrrolidin-3-yl]methyl]carbamate
CAS.NO:852857-09-1
Synonyms:(R)-1-Benzyl-3-N-Boc-aminomethyl pyrrolidine;(r)-(1-benzyl-pyrrolidin-3-ylmethyl)-carbamic acid tert-butyl ester;(R)-1-BENZYL-3-BOC-AMINOMETHYLPYRROLIDINE
Molecular Formula:C17H26N2O2
Molecular Weight:290.40100
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:400.1ºC at 760 mmHg
Density:1.059g/cm3
Index of Refraction:1.527
PSA:41.57000
Exact Mass:290.19900
LogP:3.36200
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (R)-1-Benzyl-3-N-Boc-aminomethyl pyrrolidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(R)-1-BENZYL-3-BOC-AMINOMETHYLPYRROLIDINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(r)-(1-benzyl-pyrrolidin-3-ylmethyl)-carbamic acid tert-butyl ester Use and application,(r)-(1-benzyl-pyrrolidin-3-ylmethyl)-carbamic acid tert-butyl ester technical grade,usp/ep/jp grade.
Related News: The client needed full development and product readiness with an extremely short supply of the API. In addition, the scale-up batch was small because of the low volume of product demands of their orphan drug. (4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-7-fluoro-4a-hydroxy-2,3,4,4a,5,6,7,7a-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-9-yl acetate manufacturers The green light converts the companies’ accelerated approval to a full approval for endometrial cancer that’s not microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) and for patients whose tumors have progressed following prior treatment. 2-(4,5-Dihydro-7,9-dimethyl-3H-benz(cd)azulen-3-yliden)malononitril suppliers The FDA in announcing its approval noted that four, 12-week placebo-controlled clinical studies that included a total of 1,143 participants showed Nourianz offered a statistically significant decrease from baseline in daily “off” time compared to those on placebo. methyl (2-((4-oxo-3-phenoxy-4H-chromen-7-yl)oxy)acetyl)-L-alaninate vendor & factory.
